Table 4.

Comparison of serotype specific post-vaccine titers between subjects with and without asthma

	Subjects with asthma		Subjects without asthma
Serotype	Median (μg/mL)	IQR	Median (μg/mL)	IQR	P-valueU
1	9.65	3.77–47.85	6.30	2.90–31.42	0.496
2	7.15	4.00–24.55	2.70	1.50–13.15	0.064
3	5.20	2.97–10.75	5.85	2.07–9.95	0.708
4	2.70	1.10–7.20	1.55	0.50–4.42	0.193
5	13.75	8.00–28.15	6.45	2.97–23.05	0.103
6B	23.50	3.77–69.90	9.60	3.10–28.22	0.122
7F	11.50	5.82–26.70	5.15	3.42–16.25	0.031
8	14.85	6.72–35.80	7.00	3.75–20.05	0.052
9	15.05	5.87–25.25	13.65	5.15–26.22	0.697
9V	7.85	2.87–17.10	4.95	2.22–19.67	0.627
10A	17.15	5.20–80.92	7.45	2.07–24.77	0.019
11A	4.10	2.67–15.90	5.05	1.60–18.32	0.952
12F	1.45	0.77–10.25	0.95	0.30–2.85	0.113
14	13.6	4.07–49.65	14.50	2.97–47.70	0.904
15B	7.30	3.65–20.12	11.10	3.97–32.50	0.455
17F	23.90	10.07–67.0	9.75	4.72–29.97	0.070
18C	6.30	2.12–20.20	8.40	1.80–19.27	0.805
19A	24.55	5.42–176.35	19.45	4.17–76.52	0.420
19F	11.0	3.92–27.62	12.85	4.05–30.27	0.799
20	6.85	2.9–17.77	4.40	1.65–19.87	0.317
22F	21.8	10.42–68.20	11.10	3.65–31.35	0.041
23F	12.1	4.5–61.7	10.80	2.87–32.25	0.390
33F	9.35	3.27–24.22	7.20	1.95–20.82	0.535

^UUnadjusted.

IQR: Inter-quartile range between 25^th and 75^th percentile.